>> Akums Drugs & Pharmaceuticals Ltd, established in 2004, is India’s leading pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.

>> Since inception, Akums have manufactured 4,146 commercialised formulations across over 60 dosage forms.

>> The key clients are Alembic Pharmaceuticals, Cipla, Dabur India, Dr Reddy’s Laboratories, Sun Pharmaceutical Industries etc.

>> At the upper price band of Rs 679, Akums is available at a P/E of 29.8x (FY24)and Mcap/ Sales of 2.6x (FY24), which appears to be fully priced.

>> However, considering its leading position in the industry, prestigious clientele in domestic and global markets, strong growth prospects and excluding the accounting provisions (put option liability), we assign a “Subscribe” rating on a medium to long term basis.

In its report, UBS pointed out that, typical of a long-cycle business, BEL has experienced a significant 145 per cent stock rally over the past 12 months, largely driven by a 70 per cent increase in order intake in FY24 compared to management guidance. Earnings upgrades during this period were 13 per cent, reflecting a strong valuation re-rating. READ MORE

>> Kansai Nerolac Paints Ltd. reported a 69.3% year-on-year decline in net profit for Q1FY25, though it beat analysts’ estimates.

>> The paint manufacturer recorded a net profit of Rs 225 crore for the quarter-ended June, as compared to Rs 734 crore in the same quarter last year, according to its stock exchange notification.

>> This was above the Rs 205.1-crore Bloomberg estimate

 

>> The oral hygiene product maker clocked a 33 per cent jump in net profit to Rs 363.98 crore during Q1FY25, helped by a demand pickup and good performance of products. The FMCG major reported its net profit at Rs 273.68 crore in the corresponding quarter of the previous fiscal year.

>> The state-owned RVNL has emerged as the Lowest Bidder (L1) for the ‘Development of Distribution Infrastructure at CENTRAL ZONE of Himachal Pradesh under the Revamped Reforms-based and Results-linked Distribution Sector Scheme,’ declared by HPSEBL.

>> Quality Investment Holdings, an entity of the US-based private equity firm Carlyle, likely offloaded its 6.4 per cent stake in PNB Housing Finance through a block deal on Tuesday.